How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Automobile and Transportation · Forecast 2027–2033
Hemodynamic Monitoring System Market
- By Product Type: Pulmonary Artery Catheters, Pulse Contour Cardiac Output Monitors, Transpulmonary Thermodilution Systems, Non-invasive Hemodynamic Monitors, Central Venous Pressure Monitors
- By Technology: Invasive Hemodynamic Monitoring, Minimally Invasive Hemodynamic Monitoring, Non-invasive Hemodynamic Monitoring
- By End User: Hospitals, Ambulatory Surgical Centers, Cardiac Care Units, Intensive Care Units, Emergency Care Units
- By Application: Cardiac Output Monitoring, Blood Pressure Monitoring, Fluid Management, Cardiac Function Assessment, Vascular Resistance Monitoring
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Pulmonary Artery Catheters leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.167 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.175 →
Full report · locked preview
Everything inside the Hemodynamic Monitoring System Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Technology 3
End User 5
Application 5
Companies profiled
Edwards Lifesciences Corporation
Philips Healthcare
GE Healthcare
Masimo Corporation
Medtronic plc
Nonin Medical Inc.
Mindray Medical International Limited
Nihon Kohden Corporation
Smiths Medical (a division of ICU Medical)
Stryker Corporation
Baxter International Inc.
Drägerwerk AG & Co. KGaA
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Edwards Lifesciences Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Masimo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nonin Medical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Mindray Medical International Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nihon Kohden Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Smiths Medical (a division of ICU Medical)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Stryker Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Baxter International Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Drägerwerk AG & Co. KGaA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Fukuda Denshi Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Spacelabs Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →ZOLL Medical Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,879M by 2033 · 9.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Pulmonary Artery Catheters44.1
- Pulse Contour Cardiac Output Monitors18.0
- Transpulmonary Thermodilution Systems9.7
- Non-invasive Hemodynamic Monitors11.4
- Central Venous Pressure Monitors16.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$755.9M → $1,453M · 8.5%
Europe$526.8M → $1,255M · 11.5%
Asia Pacific$481.0M → $931.0M · 8.6%
Latin America$297.8M → $634.8M · 9.9%
Middle East and Africa$229.1M → $519.9M · 10.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.852026
9.882027
9.902028
9.892029
9.912030
9.922031
9.942032
9.942033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Edwards Lifesciences Corporation11.7
- Philips Healthcare23.1
- GE Healthcare9.9
- Masimo Corporation4.3
- Medtronic plc9.9
- Nonin Medical Inc.13.2
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type28.8%
Technology26.1%
End User14.3%
Application30.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.3
- Europe26.2
- Asia Pacific19.4
- Latin America13.2
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corporation | 93 | 83 | 95 | 83 | 98 | 92 | 91 |
| Philips Healthcare | 75 | 90 | 75 | 69 | 88 | 74 | 79 |
| GE Healthcare | 72 | 85 | 75 | 65 | 80 | 65 | 74 |
| Masimo Corporation | 67 | 65 | 80 | 69 | 59 | 63 | 67 |
| Medtronic plc | 76 | 75 | 65 | 61 | 71 | 61 | 68 |
| Nonin Medical Inc. | 70 | 59 | 50 | 47 | 58 | 48 | 55 |
| Mindray Medical International Limited | 61 | 51 | 59 | 62 | 49 | 43 | 54 |
| Nihon Kohden Corporation | 60 | 47 | 40 | 51 | 41 | 56 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Edwards Lifesciences Corporation
- Philips Healthcare
- GE Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Edwards Lifesciences Corporation | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Philips Healthcare | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| GE Healthcare | ◐ | ✓ | ✓ | − | ✓ | ◐ |
| Masimo Corporation | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Medtronic plc | ◐ | − | ◐ | − | ✓ | ◐ |
| Nonin Medical Inc. | ✓ | − | − | − | − | ◐ |
| Mindray Medical International Limited | − | ◐ | − | ◐ | − | − |
| Nihon Kohden Corporation | − | ◐ | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Edwards Lifesciences Corporation91
2Philips Healthcare79
3GE Healthcare74
4Medtronic plc68
5Masimo Corporation67
6Nonin Medical Inc.55
7Mindray Medical International Limited54
8Nihon Kohden Corporation49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Edwards Lifesciences CorporationPhilips Healthcare
Challenger3
Strong scale, closing on the leaders.
GE HealthcareMasimo CorporationMedtronic plc
Niche3
Specialists in a single segment or region.
Nonin Medical Inc.Mindray Medical International LimitedNihon Kohden Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Hemodynamic Monitoring System Market — a $422M beachhead inside a $6.06B market.
Beachhead (SOM)$422Mobtainable near-term
Serviceable (SAM)$2.34Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Pulmonary Artery Catheters
Best fit — highest urgency & budget in Product Type.
Economic buyer76 fit
Pulse Contour Cardiac Output Monitors
Strong fit — clear ROI and a fast path to value.
End user68 fit
Transpulmonary Thermodilution Systems
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel31%
Digital / self-serve22%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Hemodynamic Monitoring System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified26%
Evaluation12%
Closed-won7%
$14.2KCAC
$72KLTV
5.1:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Hemodynamic Monitoring System Market is a resilient opportunity — $7.14B by 2033, compounding at 3.3%.
TAM · 2025$5.53Btoday
TAM · 2033$7.14Bforecast
CAGR3.3%2027–2033
Cumulative$56.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.14BTotal addressable market
SAM$2.69BServiceable available market
SOM$507MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.3% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.14BLarge & growingTAM by 2033 at 3.3% CAGR
$2.69BServiceable nowreachable with today’s model
$507MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.57BBear2.1% CAGR
$7.14BBase3.3% CAGR
$9.14BBull4.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Hemodynamic Monitoring System Market — a $8.65B market by 2033. Plan: grow share from 7.7% to 13.9%.
Market size · 2033$8.65Btotal addressable
Market CAGR9.5%2027–2033
Target share13.9%from 7.7% today
Revenue ambition$1.20Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.7% | 13.9% | On track |
| Revenue | $711M | $1.20B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 36.3% | 39.5% | Ahead |
| Customer retention | 88.3% | 93.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Technology capability
A defensible second engine — invest in Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $121M capacity & capability investment
- Greenlight bolt-on M&A in Technology
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Hemodynamic Monitoring System Market conversation — a $10.2B market you can size, segment and defend in minutes.
Market size · 2033$10.2Btotal opportunity
Growth8.5%CAGR to 2033
Addressable buyers1,091+accounts in scope
Typical ROI7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7×return on cost, year one
< 2 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Edwards Lifesciences CorporationPhilips HealthcareGE HealthcareMasimo CorporationMedtronic plcNonin Medical Inc.Mindray Medical International LimitedNihon Kohden Corporation+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Hemodynamic Monitoring System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Hemodynamic Monitoring System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Automobile and Transportation · scroll →Artificial Leather for Automotive Interior Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportArtificial Intelligence for Automotive and Transportation Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportArtificial Intelligence (AI) Cars and Light Trucks Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportVehicle First Aid Kits Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportArticulated Vehicle Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportArticulated Transit Bus Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportArticulated Tractors Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportArticulated Robot for Automotive Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportArticulated Lorry Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportArrow Board Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportAround View System (AVS) Market
Market size, share, segmentation and regional forecast.
$944M market · 2025 base year
View reportAromatherapy Powder For Car Air Conditioner Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.